Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4394096 | 5561172 | F | 3 | 4394096-3 | 19970502 | 19970611 | 20040630 | EXP | 34698 | BAYER PHARMACEUTICALS CORPORATION | 45 | YR | M | N | 100 | KG | 20040624 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4394096 | 1005002648 | PS | PROLASTIN | 1 | INTRAVENOUS | INTRAVENOUS | D | 601R089 | 19981025 | ||
| 4394096 | 1005019490 | C | TYLENOL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4394096 | 1005002648 | ALPHA-1 ANTI-TRYPSIN DEFICIENCY |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4394096 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4394096 | HAEMOPTYSIS |
| 4394096 | INFUSION RELATED REACTION |
| 4394096 | LOBAR PNEUMONIA |
| 4394096 | PRURITUS |
| 4394096 | SPUTUM PURULENT |
| 4394096 | URTICARIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4394096 | HP |
| 4394096 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4394096 | 1005002648 | 19970429 |